Tag: Spdr S&P Biotech Etf

‘Buying stuff like it’s going out of fashion’: Biotech M&A on track for best year since pre-Covid

Hantavirus cases spark surge in pharma and biotech stocks — here’s why

Pharma bets a little-known form of cholesterol will underpin its next blockbuster heart drugs

Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion

Trump policies, China’s biotech boom are ending Europe’s pharma powerhouse era

Stocks making the biggest moves midday: Palantir, Flutter, United Airlines, Synopsys, Insmed & more

How CNBC Cures is bringing rare disease stories to a national audience

Vertex passes key test in quest to treat kidney diseases

FDA vaccine head will step down in April after string of controversial decisions

FDA reversals leave investors worrying about the fates of other experimental drugs